Armata Pharmaceuticals (ARMP) Return on Invested Capital (2017)

Armata Pharmaceuticals' (ARMP) quarterly Return on Invested Capital came in at 0.01% in Q4 2017.

Armata Pharmaceuticals (ARMP) Return on Invested Capital (2017) Analysis & Trends

Armata Pharmaceuticals has disclosed Return on Invested Capital across 1 years of filings, most recently posting 0.01% for Q4 2017.

Return on Invested Capital for Q4 2017 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was 0.01% (changed N/A YoY), and the FY2018 annual result was 0.01%, changed 0.0% from the prior year.
Return on Invested Capital came in at 0.01% for Q4 2017 at Armata Pharmaceuticals.
In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q4 2017 to a low of 0.01% in Q4 2017.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	0.01%
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-0.01%
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-0.01%
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	0.00%
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Armata Pharmaceuticals	275.44 Mn	270.68 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2017	-0.01%